Feed excerpt — reported by Nature
Nature, Published online: 13 October 2026; doi:10.1038/d41586-026-03252-3Compounds inspired by the blockbuster weight-loss drugs are also being trialled for schizophrenia and Parkinson’s disease, among other conditions.
MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at Nature →